The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 19, 2025

Filed:

Aug. 26, 2021
Applicant:

Anaptysbio, Inc., San Diego, CA (US);

Inventors:

Peter Bowers, San Diego, CA (US);

Andrew John Mcknight, San Diego, CA (US);

David J. King, Encinitas, CA (US);

Marco Londei, San Diego, CA (US);

Assignee:

ANAPTYSBIO, INC., San Diego, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61P 29/00 (2006.01); A61P 37/06 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2866 (2013.01); A61K 39/39533 (2013.01); A61P 29/00 (2018.01); A61P 37/06 (2018.01); A61K 39/395 (2013.01); A61K 2039/505 (2013.01); C07K 2317/33 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01);
Abstract

The invention relates to an isolated immunoglobulin heavy chain polypeptide and an isolated immunoglobulin light chain polypeptide that bind to a protein encoded by the interleukin 36 receptor (IL-36R). The invention provides an IL-36R-binding agent that comprises the aforementioned immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide. The invention also provides related vectors, compositions, and methods of using the IL-36R-binding agent to treat a disorder or disease that is responsive to IL-36R inhibition, such as cancer, an infectious disease, or an autoimmune disease.


Find Patent Forward Citations

Loading…